Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043378 · ClinicalTrials.gov registry record
Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 201
- Enrollment target
NCT03043378: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT03043378 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03043378 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
The goal of this research study is to learn how frequently cancer patients in the Supportive Care Center have chronic, non-malignant pain. Chronic, non-malignant pain is pain that is neither related to cancer nor its treatment and lasts beyond the normal tissue healing time of 3 months.
Primary Outcome
Frequency assessed by Edmonton Symptom Assessment Scale (ESAS-FS)
Interventions
- BEHAVIORAL Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2023-03-23 |
What the finished NCT03043378 record still lists
NCT03043378 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT03043378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03043378 about?
NCT03043378 is a clinical study titled "Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic". The goal of this research study is to learn how frequently cancer patients in the Supportive Care Center have chronic, non-malignant pain. Chronic, non-malignant pain is pain that is neither related to cancer nor its treatment and lasts beyond the normal tissue healing time of 3 months.
What is the current status of trial NCT03043378?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2018-07-31. Estimated completion is 2023-03-23.
What interventions are being tested in trial NCT03043378?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT03043378?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI